Showing results (191-200 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|July 10, 2019
Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case seriesJaclyn LoPiccolo, Megan D Schollenberger, Sumia Dakhil, et al.Journal for Immunotherapy of Cancer|July 12, 2019
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor siteAlessandra Lopes, Sara Feola, Sophie Ligot, et al.Journal for Immunotherapy of Cancer|July 12, 2019
Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitorsMenno Tamminga, Sanne de Wit, T Jeroen N Hiltermann, et al.Journal for Immunotherapy of Cancer|July 12, 2019
Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumabJulia Ouaknine Krief, Pierre Helly de Tauriers, Coraline Dumenil, et al.Journal for Immunotherapy of Cancer|June 29, 2019
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patientsMarit M Melssen, Gina R Petroni, Kimberly A Chianese-Bullock, et al.Journal for Immunotherapy of Cancer|February 23, 2022
Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cellsXiaowu Bai, Chi Chun Wong, Yasi Pan, et al.Journal for Immunotherapy of Cancer|February 23, 2022
Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysisSiming Li, Xiaowen Wu, Xieqiao Yan, et al.Journal for Immunotherapy of Cancer|February 3, 2022
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancerPuran Zhang, Yun Gu, Hanji Fang, et al.Journal for Immunotherapy of Cancer|February 2, 2022
Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironmentXiwei Wang, Yanmei Zhang, Xiaofeng Mu, et al.Journal for Immunotherapy of Cancer|February 4, 2022
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapyJoanne Weidhaas, Nicholas Marco, Aaron W Scheffler, et al.Pageof 424